Zhejiang Hisun Pharma Invests in US-based Sagent Pharma

Zhejiang Hisun Pharmaceutical Co. Ltd. revealed that it will make a $10 million investment in Sagent Pharma, a relatively new company headquartered near Chicago, Illinois. The company will purchase 7 million shares at $1.40 each in privately held Sagent, equivalent to a 4.5% stake. More details... Stock Symbol: (SHA: 600267)